Strides Pharma Science informs about press release

27 Sep 2019 Evaluate

Strides Pharma Science has informed about press release titled: ‘Strides receives USFDA approval for Solifenacin Succinate Tablets’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

882.00 12.60 (1.45%)
20-Jan-2026 09:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1662.40
Dr. Reddys Lab 1164.45
Cipla 1386.10
Zydus Lifesciences 881.95
Lupin 2164.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×